Skip to Navigation
Skip to Main Content
Skip to Related Content

Advertisement

U.S. Markets open in 6 hrs 37 mins

S&P Futures
5,749.00
+5.75(+0.10%)
Dow Futures
41,987.00
+31.00(+0.07%)
Nasdaq Futures
20,120.00
+34.00(+0.17%)
Russell 2000 Futures
2,231.00
-0.10(-0.00%)
Crude Oil
71.51
+0.04(+0.06%)
Gold
2,745.90
-0.30(-0.01%)

Amphastar Pharmaceuticals, Inc. (AMPH)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD

Follow

Visitors trend2W10W9M

50.59

-0.14

(-0.28%)

At close: 04:00PM EST

50.99

+0.40

(+0.79%)

After hours:

05:43PM EST

Currency in USD

Valuation Measures⁴

Market Cap (intraday)	2.48B
Enterprise Value	2.88B
Trailing P/E	16.06
Forward P/E	N/A
PEG Ratio (5 yr expected)	N/A
Price/Sales (ttm)	3.76
Price/Book (mrq)	3.47
Enterprise Value/Revenue	4.04
Enterprise Value/EBITDA	9.63

Trading Information

Stock Price History

Beta (5Y Monthly)	0.83
52-Week Change ³	N/A
S&P500 52-Week Change ³	N/A
52 Week High ³	65.92
52 Week Low ³	36.56
50-Day Moving Average ³	48.28
200-Day Moving Average ³	45.25

Share Statistics

Avg Vol (3 month) ³	333.48k
Avg Vol (10 day) ³	261.28k
Shares Outstanding ⁵	48.96M
Implied Shares Outstanding ⁶	N/A
Float ⁸	37.69M
% Held by Insiders ¹	22.33%
% Held by Institutions ¹	74.02%
Shares Short (Oct 15, 2024) ⁴	4.23M
Short Ratio (Oct 15, 2024) ⁴	13.18
Short % of Float (Oct 15, 2024) ⁴	13.16%
Short % of Shares Outstanding (Oct 15, 2024) ⁴	8.65%
Shares Short (prior month Sep 13, 2024) ⁴	4.13M

Dividends & Splits

Forward Annual Dividend Rate ⁴	N/A
Forward Annual Dividend Yield ⁴	N/A
Trailing Annual Dividend Rate ³	0.00
Trailing Annual Dividend Yield ³	0.00%
5 Year Average Dividend Yield ⁴	N/A
Payout Ratio ⁴	0.00%
Dividend Date ³	N/A
Ex-Dividend Date ⁴	N/A
Last Split Factor ²	N/A
Last Split Date ³	N/A

Financial Highlights

Fiscal Year

Fiscal Year Ends	Dec 31, 2023
Most Recent Quarter (mrq)	Jun 30, 2024

Profitability

Profit Margin	23.36%
Operating Margin (ttm)	30.27%

Management Effectiveness

Return on Assets (ttm)	10.13%
Return on Equity (ttm)	25.57%

Income Statement

Revenue (ttm)	712.89M
Revenue Per Share (ttm)	14.72
Quarterly Revenue Growth (yoy)	25.20%
Gross Profit (ttm)	N/A
EBITDA	284.16M
Net Income Avi to Common (ttm)	166.52M
Diluted EPS (ttm)	3.15
Quarterly Earnings Growth (yoy)	45.30%

Balance Sheet

Total Cash (mrq)	217.78M
Total Cash Per Share (mrq)	4.47
Total Debt (mrq)	620.58M
Total Debt/Equity (mrq)	87.00
Current Ratio (mrq)	3.52
Book Value Per Share (mrq)	14.57

Cash Flow Statement

Operating Cash Flow (ttm)	212.6M
Levered Free Cash Flow (ttm)	35.29M